NCT03172481View on ClinicalTrials.gov

PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

August 19, 2017

Study Completion Date

December 19, 2017

Conditions
ADHD
Interventions
DRUG

PRC-063 oral capsules

Daily dose

DRUG

Placebo oral capsules

Daily dose

Trial Locations (6)

32751

Meridien Research Inc., Maitland

33143

Qps Mra Llc, Miami

34201

Meridien Research Inc., Bradenton

77007

Bayou City Research, Houston

89128

Center for Psychiatry and Behavioral Medicine, Las Vegas

92660

AVIDA Inc., Newport Beach

All Listed Sponsors
lead

Purdue Pharma, Canada

INDUSTRY

NCT03172481 - PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD | Biotech Hunter | Biotech Hunter